Thymosin Alpha-1
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: Thymosin Alpha-1 (Talpha1) is a 28-amino-acid peptide naturally produced by the thymus gland, essential for programming, training, and regulating the human immune system.
How it works: It acts as an immune system master-regulator. Through Toll-like receptors (TLR9 and TLR2), it ramps up underactive immune responses by stimulating cytotoxic T-cells, Natural Killer (NK) cells, and dendritic cells to attack viruses and infections. Simultaneously, it increases anti-inflammatory T-regulatory (Treg) cells, preventing the immune system from overreacting and attacking the body's own tissues.
Why researchers study it: Studied worldwide for treating chronic viral infections (Hepatitis B/C, HIV), preventing respiratory illnesses, enhancing vaccine responsiveness, calming autoimmune flare-ups, and supporting immune recovery during chemotherapy.
Compound & Molecular Specifications
Certificate of Analysis StandardsFrequently Stacked with TB-500 (Thymosin Beta-4 Frag)
Clinically verified combinations activating complementary physiological pathways without receptor competition.
BPC-157 Arginate (Stable Oral/SubQ)
Stable L-arginate salt of BPC-157 ensures robust microvascular VEGFR2 capillary ingrowth and gut barrier recovery, perfectly paired with TB-500 systemic G-actin sequestration for organized scar-free tissue repair.
BPC-157 (Pentadecapeptide)
BPC-157 acts locally by accelerating microvascular angiogenesis via VEGFR2 and stabilizing granulation tissue, while TB-500 sequesters G-actin to drive rapid systemic cell migration and prevent fibrous adhesion/scar formation.
